GalcanezumAb for prevention of high frequency episodic and chronic migraine in the Real Life in ITaly: a multicenter prospective cohort study (the GARLIT study)

被引：0

作者：

Vernieri, F. ^{[1
]}

Altamura, C. ^{[1
]}

Brunelli, N. ^{[1
]}

Costa, C. M. ^{[1
]}

Aurilia, C. ^{[2
]}

Egeo, G. ^{[2
]}

Fofi, L. ^{[2
]}

Favoni, V. ^{[3
]}

Pierangeli, G. ^{[3
]}

Lovati, C. ^{[4
]}

Aguggia, M. ^{[5
]}

Bertuzzo, D. ^{[5
]}

D'Onofrio, F. ^{[6
]}

Doretti, A. ^{[7
,8
]}

Di Fiore, P. ^{[9
]}

Frediani, F. ^{[9
]}

Finocchi, C. ^{[10
]}

Rao, R. ^{[11
]}

Di Cola, F. Schiano ^{[11
]}

Bono, F. ^{[12
]}

Ranieri, A. ^{[13
]}

Albanese, M. ^{[14
]}

Cevoli, S. ^{[3
]}

Barbanti, P. ^{[2
]}

机构：

[1] Campus Biomed Univ Rome, Neurol, Rome, Italy

[2] IRCCS San Raffaele Pisana, Headache & Pain Unit, Rome, Italy

[3] IRCCS Ist Sci Neurol Bologna, Bologna, Italy

[4] Univ Hosp L Sacco, Neurol Unit, Milan, Italy

[5] Asti Hosp, Neurol & Stroke Unit, Asti, Italy

[6] Giuseppe Moscati Hosp, Neurol Unit, Avellino, Italy

[7] Ist Auxol Italiano, IRCCS, Stroke Unit, Neurol, Milan, Italy

[8] Lab Neurosci, Milan, Italy

[9] San Carlo Borromeo Hosp, ASST Santi Paolo & Carlo Milan, Headache Ctr, Neurol & Stroke Unit, Milan, Italy

[10] IRCCS Osped Policlin San Martino, Genoa, Italy

[11] Univ Brescia, Dept Clin & Expt Sci, Neurol Unit, Brescia, Italy

[12] AOU Mater Domini, Neurol Unit, Catanzaro, Italy

[13] A Cardarelli Hosp, Headache Ctr, Neurol & Stroke Unit, Naples, Italy

[14] Univ Hosp Rome Tor Vergata, Dept Syst Med, Rome, Italy

来源：

CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

AL057

引用

页码：29 / 30

页数：2

共 50 条

[41] Headache Impact of Chronic and Episodic Migraine: Results From the American Migraine Prevalence and Prevention Study
Buse, Dawn
Manack, Aubrey
Serrano, Daniel
Reed, Michael
Varon, Sepideh
Turkel, Catherine
Lipton, Richard
HEADACHE, 2012, 52 (01): : 3 - 17
[42] Long term (1-year) effectiveness, safety and tolerability of fremanezumab in migraine: a real-life, prospective, cohort, multicenter study
Egeo, Gabriella
Aurilia, Cinzia
Orlando, Bianca
Fiorentini, Giulia
D'Onofrio, Florindo
Albanese, Maria
Messina, Roberta
Di Fiore, Paola
Zucco, Maurizio
Filippi, Massimo
Bartolini, Marco
Bono, Francesco
Grazzi, Licia
Querzani, Pietro
Borrello, Laura
Doretti, Alberto
Gai, Annalisa
Proietti, Stefania
Bonassi, Stefano
Vernieri, Fabrizio
Torelli, Paola
Barbanti, Piero
CEPHALALGIA, 2023, 43 (1supp) : 257 - 258
[43] The PEARL study protocol: a pan-european prospective observational study of fremanezumab effectiveness in patients with chronic or episodic migraine in the real world
Ashina, M.
Amin, F. M.
Kokturk, P.
Cohen, J. M.
Konings, M.
Tassorelli, C.
Mitsikostas, D. -D.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 607 - 607
[44] Napping behavior in adults with episodic migraine: a six-week prospective cohort study
Vgontzas, Angeliki
Mostofsky, Elizabeth
Hagan, Kobina
Rueschman, Michael
Mittleman, Murray A.
Bertisch, Suzanne M.
SLEEP, 2022, 45 (03)
[45] Long term (48-weeks) effectiveness, safety and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in real-world: the EARLY 2 study
Aurilia, C.
Cevoli, S.
Egeo, G.
Fofi, L.
Messina, R.
Salerno, A.
Torelli, P.
Albanese, M.
Carnevale, A.
Bono, F.
D'Amico, D.
Filippi, M.
Altamura, C.
Vernieri, F.
Colombo, B.
Frediani, F.
Mercuri, B.
D'Onofrio, F.
Grazzi, L.
Aguggia, M.
Favoni, V.
Finocchi, C.
Di Fiore, P.
Costa, C. M.
Brunelli, N.
Fallacara, A.
Bertuzzo, D.
Zucco, M.
Di Clemente, L.
Trimboli, M.
Pascarella, A.
Manzo, L.
Barbanti, P.
CEPHALALGIA, 2021, 41 (1_SUPPL) : 23 - 23
[46] Long term (48-weeks) effectiveness, safety and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in real-world: the EARLY 2 study
Aurilia, C.
Cevoli, S.
Egeo, G.
Fofi, L.
Messina, R.
Salerno, A.
Torelli, P.
Albanese, M.
Carnevale, A.
Bono, F.
D'Amico, D.
Filippi, M.
Altamura, C.
Vernieri, F.
Colombo, B.
Frediani, F.
Mercuri, B.
D'Onofrio, F.
Grazzi, L.
Aguggia, M.
Favoni, V.
Finocchi, C.
Di Fiore, P.
Costa, C. M.
Brunelli, N.
Fallacara, A.
Bertuzzo, D.
Zucco, M.
Di Clemente, L.
Trimboli, M.
Pascarella, A.
Manzo, L.
Barbanti, P.
JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 16 - 16
[47] Prospective cohort study of routine exercise and headache outcomes among adults with episodic migraine
Hagan, Kobina K.
Li, Wenyuan
Mostofsky, Elizabeth
Bertisch, Suzanne M.
Vgontzas, Angeliki
Buettner, Catherine
Mittleman, Murray A.
HEADACHE, 2021, 61 (03): : 493 - 499
[48] Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study
Barbanti, Piero
Aurilia, Cinzia
Cevoli, Sabina
Egeo, Gabriella
Fofi, Luisa
Messina, Roberta
Salerno, Antonio
Torelli, Paola
Albanese, Maria
Carnevale, Antonio
Bono, Francesco
D'Amico, Domenico
Filippi, Massimo
Altamura, Claudia
Vernieri, Fabrizio
HEADACHE, 2021, 61 (09): : 1351 - 1363
[49] Long term (48-weeks) effectiveness, safety and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in real-world: The early 2 study
Aurilia, Cinzia
Cevoli, Sabina
Egeo, Gabriella
Fofi, Luisa
Messina, Roberta
Salerno, Antonio
Torelli, Paola
Albanese, Maria
Carnevale, Antonio
Bono, Francesco
D'Amico, Domenico
Filippi, Massimo
Altamura, Claudia
Vernieri, Fabrizio
Colombo, Bruno
Frediani, Fabio
Mercuri, Bruno
D'Onofrio, Florindo
Grazzi, Licia
Aguggia, Marco
Favoni, Valentina
Finocchi, Cinzia
Di Fiore, Paola
Costa, Carlemina Maria
Brunelli, Nicoletta
Fallacara, Adriana
Bertuzzo, Davide
Zucco, Maurizio
Di Clemente, Laura
Trimboli, Michele
Pascarella, Angelo
Manzo, Lucia
Barbanti, Piero
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
[50] Gaps in the Acute Treatment of Episodic and Chronic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
Lipton, Richard
Manack, Aubrey
Serrano, Daniel
Buse, Dawn
NEUROLOGY, 2013, 80

← 1 2 3 4 5 →